Literature DB >> 18796124

Rifaximin for the treatment of newly diagnosed Crohn's disease: a case series.

Ira Shafran, Patricia Burgunder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18796124     DOI： 10.1111/j.1572-0241.2008.01982_16.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity.

Authors:  Ira Shafran; Patricia Burgunder
Journal:  Dig Dis Sci       Date:  2010-01-29       Impact factor: 3.199

Review 2.  Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.

Authors:  Hoonmo L Koo; Herbert L DuPont
Journal:  Curr Opin Gastroenterol       Date:  2010-01       Impact factor: 3.287

Review 3.  Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.

Authors:  Francesca Romana Ponziani; Viviana Gerardi; Silvia Pecere; Francesca D'Aversa; Loris Lopetuso; Maria Assunta Zocco; Maurizio Pompili; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

4.  Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques.

Authors:  Ivona Pandrea; Cuiling Xu; Jennifer L Stock; Daniel N Frank; Dongzhu Ma; Benjamin B Policicchio; Tianyu He; Jan Kristoff; Elaine Cornell; George S Haret-Richter; Anita Trichel; Ruy M Ribeiro; Russell Tracy; Cara Wilson; Alan L Landay; Cristian Apetrei
Journal:  PLoS Pathog       Date:  2016-01-14       Impact factor: 6.823
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.